Showing 6471-6480 of 20414 results for "".
Another Day in the Frontal Lobe
https://reachmd.com/programs/clinicians-roundtable/another-day-in-the-frontal-lobe/1118/Dr. Katrinia Firlik discusses the writing and publishing of her book, "Another Day in the Frontal Lobe: A Brain Surgeon Exposes Life on the Inside."Sexual Problems of Long Term Cancer Survivors
https://reachmd.com/programs/clinicians-roundtable/sexual-problems-of-long-term-cancer-survivors/1467/Why do the sexual problems of long term cancer survivors deserve special attention? Dr. Shira Johnson discusses with Dr. Stacy Lindau the study she and her colleagues conducted which is published in the August 2007 issue of Gynecologic Oncology.Are You in a Groove or in a Rut?
https://reachmd.com/programs/clinicians-roundtable/are-you-in-a-groove-or-in-a-rut/1216/Join Dr. Linda Clever, founder of RENEW, a not-for-profit aimed at helping people maintain and regain enthusiasm help you identify and improve your own psyche in your medical practice.The Challenging Demands Faced by the Neurosurgeon
https://reachmd.com/programs/clinicians-roundtable/the-challenging-demands-faced-by-the-neurosurgeon/1120/Dr. Katrina Firlik, author of "Another Day in the Frontal Lobe: a Brain Surgeon Exposes Life on the Inside" discusses the practice of neurosurgery.Defining Chronic Ocular Surface Pain: Causes, Clues, and Complexity
https://reachmd.com/programs/eye-on-ocular-health/defining-chronic-ocular-surface-pain-causes-clues-and-complexity/37273/Chronic ocular surface pain (COSP) is a multifaceted condition often described by patients as dryness, burning, or grittiness. Despite its prevalence, it frequently presents in relationship to other diseases, which makes understanding these connections and figuring out what exactly to target essentiNot All VMAT2s Are the Same: Understanding the PK/PD Differences
https://reachmd.com/programs/cme/not-all-vmat2s-are-the-same-understanding-the-pkpd-differences/56645/Improve your diagnostic and screening skills for tardive dyskinesia and learn about the important role of VMAT2 inhibitors in the management of this disorder.Sexuality After Cancer
https://reachmd.com/programs/clinicians-roundtable/sexuality-after-cancer/756/Join Dr. Kydd as she discusses intimacy and sexuality after surviving cancer.MS Masters Toolbox: Cramps, Spasms, and Spasticity
https://reachmd.com/programs/practical-neurology/cramps-spasms-and-spasticity/31200/In this series, Vito Arena, MD and Ilya Kister, MD from the New York University School of Medicine Comprehensive MS Care Center discuss tools for managing multiple sclerosis symptoms. These gems are guided by research and intended to improve quality of life for people with MS. Episode 4 provides tooVMAT2 in the Real World: Recently Presented PRO Data That Should Change TD Practice
https://reachmd.com/programs/cme/vmat2-in-the-real-world-recently-presented-pro-data-that-should-change-td-practice/56650/Improve your diagnostic and screening skills for tardive dyskinesia and learn about the important role of VMAT2 inhibitors in the management of this disorder.ATTRibute-CM Findings on Acoramidis and Cumulative CV Events
https://reachmd.com/programs/on-the-frontlines-of-attr-cm/attribute-cm-acoramidis-cv-events/49036/An exploratory analysis of the ATTRibute-CM trial revealed that acoramidis meaningfully reduces cumulative cardiovascular events as early as one month into treatment. Learn more about these findings and their implications for patients with transthyretin amyloid cardiomyopathy (ATTR-CM) as Ryan Quigl